Clinical trials
Observational Multiple Myeloma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Celgene | 2 |
| Janssen Korea, Ltd., Korea | 2 |
| Asan Medical Center | 1 |
| Boryung Pharmaceutical Co., Ltd | 1 |
| Eisai Korea Inc. | 1 |
| Pfizer | 1 |
| Saint Vincent's Hospital, Korea | 1 |
| Samsung Medical Center | 1 |
| Seoul National University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 16 |
| Recurrence | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Lymphoid | 1 |
| Lymphoma | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.